Company Sector
Rare Disease
Rare Disease groups companies developing therapies for smaller patient populations with high unmet need. These businesses are often built around genetically defined disorders, orphan indications, and targeted commercial strategies with highly specialized clinical programs.
Why watch Rare Disease
This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.
Latest Rare Disease news
The latest feed items from companies currently grouped under Rare Disease.
- 01
- 02
TARAProtara Therapeutics Announces Third Quarter 2026 Financial Results and Provides a Business Update
Source: Protara Therapeutics
- 03
- 04
ETONEton Pharmaceuticals to Present at 2026 Jefferies Global Healthcare Conference in London
Source: Eton Pharmaceuticals
- 05
BCRXBioCryst to Present at Upcoming Investor Conferences
Source: BioCryst Pharmaceuticals
- 06
ARWRArrowhead Pharmaceuticals Refinances Existing Credit Facility, Lowering Borrowing Costs and Extending Maturity
Source: Arrowhead Pharmaceuticals
- 07
BCRXBioCryst Reports Third Quarter 2026 Financial Results
Source: BioCryst Pharmaceuticals
- 08
ARWRArrowhead Pharmaceuticals to Webcast 2026 Fiscal Year-End Results
Source: Arrowhead Pharmaceuticals
- 09
- 10
PTCTPTC Therapeutics Board of Directors Authorizes $500 Million Share Repurchase Program
Source: PTC Therapeutics, Inc.
- 11
PTCTPTC Therapeutics to Participate in Upcoming Investor Conferences
Source: PTC Therapeutics, Inc.
- 12
- 13
ABEOAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Source: Abeona Therapeutics
- 14
ARWRArrowhead Pharmaceuticals to Present Important Clinical Data at the American Heart Association Scientific Sessions 2026
Source: Arrowhead Pharmaceuticals
- 15
- 16
PTCTPTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Source: PTC Therapeutics, Inc.
- 17
PTCTPTC Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results
Source: PTC Therapeutics, Inc.
- 18
- 19
- 20
Companies in Rare Disease
46 companies tagged with Rare Disease.
Frequently Asked Questions
What does the Rare Disease sector include?
Rare Disease groups companies developing therapies for smaller patient populations with high unmet need. These businesses are often built around genetically defined disorders, orphan indications, and targeted commercial strategies with highly specialized clinical programs.
How many companies are currently tagged with Rare Disease?
46 companies are currently grouped under Rare Disease on BioPharmSignal.
Which companies are most visible in the Rare Disease group right now?
ABEO, ACAD, AGLE, AGIO are among the companies currently shown on this sector page.
How can I watch news for Rare Disease?
Use the Watch button on this page to subscribe to Rare Disease headlines and related company updates through your BioPharmSignal saved filters.
What kinds of updates usually appear for Rare Disease?
The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in Rare Disease.